Albuterol Dosing for a Four-Year-Old Child
For a 4-year-old child with asthma or bronchospasm, the recommended albuterol dose is 0.15 mg/kg (minimum 2.5 mg) via nebulizer every 20 minutes for 3 doses, then 0.15-0.3 mg/kg every 1-4 hours as needed. 1
Nebulizer Administration
Standard nebulizer solution (0.083% or 0.5%):
- Initial treatment: 2.5 mg (0.5 mL of 0.5% solution or 3 mL of 0.083% solution) every 20 minutes for 3 doses
- Maintenance: 0.15-0.3 mg/kg up to 10 mg every 1-4 hours as needed
- For continuous nebulization: 0.5 mg/kg/hour up to 10-15 mg/hour 1
Dilution: Dilute in a minimum of 2-3 mL of saline solution for adequate nebulization 1
Administration time: Typically 5-15 minutes per treatment 2
Metered-Dose Inhaler (MDI) Administration
- With spacer/valved holding chamber and face mask:
Important Clinical Considerations
Delivery Method Selection
- Nebulizer: Preferred for acute exacerbations or when higher doses are needed
- MDI with spacer: Effective for maintenance therapy and mild symptoms
Monitoring and Safety
Potential adverse effects:
- Tachycardia, skeletal muscle tremor, hypokalemia
- Increased lactic acid, headache, hyperglycemia 1
Monitoring parameters:
- Heart rate and blood pressure
- Clinical response (work of breathing, oxygen saturation)
- Potassium levels if receiving frequent or continuous treatments
Special Considerations
- Oxygen source: Oxygen is the preferred gas source for nebulization 1
- Levalbuterol alternative: If using levalbuterol instead of racemic albuterol, use half the dose (0.075 mg/kg) 1, 3
- Increasing use warning: An increasing need for albuterol or lack of expected effect indicates diminished asthma control 1
Practical Tips
- For nebulizer treatments, ensure proper fit of mask over nose and mouth
- Clean the child's face after each treatment to prevent local side effects 1
- MDI administration requires proper technique and coaching by trained personnel 1
- Periodically clean HFA actuator as drug may plug orifice 1
This dosing recommendation is based on national guidelines for pediatric asthma management and is appropriate for a 4-year-old child requiring bronchodilator therapy.